Skip to content
Screener

Amgen AMGN Business Combination, Contingent Consideration, Liability

Business Combination, Contingent Consideration, Liability at other companies

The RMR Group logo
The RMR GroupRMR
$3.64M-75.0%
Amgen logo
AmgenAMGN
$171M+90.0%
Medline, Inc. logo
Medline, Inc.MDLN
$29M
LivaNova logo
LivaNovaLIVN
$42.12M
Cushman & Wakefield logo
Cushman & WakefieldCWK
$8.5M
Crane NXT, Inc. logo
Crane NXT, Inc.CXT
$1.3M-13.3%

Other financials

Income statement

See full
Revenue$10.1B+9.5%
Gross profit$7.2B+17.4%
Operating income$3.5B+32.3%
Net income$2.4B+65.9%
EPS (diluted)$4.37+64.9%

Balance sheet

See full
Cash & equivalents$574.0M+5.9%
Total debt$57.3B+2.0%
Total equity$11.7B+57.4%
Total assets$95.6B+8.8%

Cash flow

See full
Operating cash flow$4.0B+75.5%
CapEx$513.0M+39.0%
Free cash flow$3.5B+82.6%

Valuation

See full
Market cap$219.02B+42.9%
Enterprise value$275.75B+32.0%
P/E25.1×+1.9×
P/S5.8×+1.4×

Profitability

See full
Gross margin69.5%+5.0pp
Operating margin30%+6.5pp
Net margin23%+4.0pp
FCF margin26.7%-3.7pp

Returns & leverage

See full
Return on equity91.5%-7.7pp
Debt / equity4.9×-2.7×
Current ratio1.4×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationLiability.

The source filing: Amgen’s 10-Q, filed August 5, 2026.

Filed
Aug 4, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000318154-26-000126
Fair value measurement as of June 30, 2026, using:Quoted prices in active markets for identical assets(Level 1)Significantother observableinputs(Level 2)Significantunobservableinputs(Level 3)Total
Total assets$16,660$2,935$19,595
Liabilities:
Derivatives:
Foreign currency forward contracts$107$107
Cross-currency swap contracts329329
Interest rate swap contracts330330
Contingent consideration obligations171171
Total liabilities$766$171$937

Item 1. FINANCIAL STATEMENTS

FAQ

What is Amgen's business combination, contingent consideration, liability?
Amgen (AMGN) reported business combination, contingent consideration, liability of $171M in Q2 2026.
How has Amgen's business combination, contingent consideration, liability changed year-over-year?
Amgen's business combination, contingent consideration, liability increased by 90.0% year-over-year, from $90M to $171M.
What is the long-term trend for Amgen's business combination, contingent consideration, liability?
Over 5 years (2020 to 2025), Amgen's business combination, contingent consideration, liability has grown at a 37.3% compound annual growth rate (CAGR), from $33M to $161M.
What does business combination, contingent consideration, liability mean?
Business Combination, Contingent Consideration, Liability

Ask your AI about Amgen's business combination, contingent consideration, liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude